A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Market Analysis and Insights: Global Contract Dose Manufacturing Market
The global Contract Dose Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Contract Dose Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Contract Dose Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Contract Dose Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Contract Dose Manufacturing include Lonza, Catalent, Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics Contract Services and AMRI, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Contract Dose Manufacturing is widely used in various fields, such as Pharmaceutical Company, Biotechnology Company, Generic Company and Others, etc. Pharmaceutical Company provides greatest supports to the Contract Dose Manufacturing industry development. In 2023, global % revenue of Contract Dose Manufacturing went into Pharmaceutical Company filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Contract Dose Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Contract Dose Manufacturing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Contract Dose Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contract Dose Manufacturing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Contract Dose Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Contract Dose Manufacturing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Lonza
Catalent
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics Contract Services
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup(Eurofins)
Thermo Fisher Scientific
Piramal Pharma Solutions
AbbVie Contract Manufacturing
Baxter BioPharma Solutions
Fareva
NextPharma
Emergent BioSolution
Segment by Type
API Development
Manufacturing
Drug Delivery
Others
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Contract Dose Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contract Dose Manufacturing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Dose Manufacturing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Contract Dose Manufacturing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 API Development
1.2.3 Manufacturing
1.2.4 Drug Delivery
1.2.5 Others
1.3 Market by Application
1.3.1 Global Contract Dose Manufacturing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contract Dose Manufacturing Market Perspective (2019-2030)
2.2 Global Contract Dose Manufacturing Growth Trends by Region
2.2.1 Contract Dose Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Contract Dose Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Contract Dose Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Contract Dose Manufacturing Market Dynamics
2.3.1 Contract Dose Manufacturing Industry Trends
2.3.2 Contract Dose Manufacturing Market Drivers
2.3.3 Contract Dose Manufacturing Market Challenges
2.3.4 Contract Dose Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Contract Dose Manufacturing by Players
3.1.1 Global Contract Dose Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Contract Dose Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Contract Dose Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Contract Dose Manufacturing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Contract Dose Manufacturing Market Concentration Ratio
3.4.1 Global Contract Dose Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contract Dose Manufacturing Revenue in 2023
3.5 Global Key Players of Contract Dose Manufacturing Head office and Area Served
3.6 Global Key Players of Contract Dose Manufacturing, Product and Application
3.7 Global Key Players of Contract Dose Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Contract Dose Manufacturing Breakdown Data by Type
4.1 Global Contract Dose Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Contract Dose Manufacturing Forecasted Market Size by Type (2025-2030)
5 Contract Dose Manufacturing Breakdown Data by Application
5.1 Global Contract Dose Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Contract Dose Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Contract Dose Manufacturing Market Size (2019-2030)
6.2 North America Contract Dose Manufacturing Market Size by Type
6.2.1 North America Contract Dose Manufacturing Market Size by Type (2019-2024)
6.2.2 North America Contract Dose Manufacturing Market Size by Type (2025-2030)
6.2.3 North America Contract Dose Manufacturing Market Share by Type (2019-2030)
6.3 North America Contract Dose Manufacturing Market Size by Application
6.3.1 North America Contract Dose Manufacturing Market Size by Application (2019-2024)
6.3.2 North America Contract Dose Manufacturing Market Size by Application (2025-2030)
6.3.3 North America Contract Dose Manufacturing Market Share by Application (2019-2030)
6.4 North America Contract Dose Manufacturing Market Size by Country
6.4.1 North America Contract Dose Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Contract Dose Manufacturing Market Size by Country (2019-2024)
6.4.3 North America Contract Dose Manufacturing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Contract Dose Manufacturing Market Size (2019-2030)
7.2 Europe Contract Dose Manufacturing Market Size by Type
7.2.1 Europe Contract Dose Manufacturing Market Size by Type (2019-2024)
7.2.2 Europe Contract Dose Manufacturing Market Size by Type (2025-2030)
7.2.3 Europe Contract Dose Manufacturing Market Share by Type (2019-2030)
7.3 Europe Contract Dose Manufacturing Market Size by Application
7.3.1 Europe Contract Dose Manufacturing Market Size by Application (2019-2024)
7.3.2 Europe Contract Dose Manufacturing Market Size by Application (2025-2030)
7.3.3 Europe Contract Dose Manufacturing Market Share by Application (2019-2030)
7.4 Europe Contract Dose Manufacturing Market Size by Country
7.4.1 Europe Contract Dose Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Contract Dose Manufacturing Market Size by Country (2019-2024)
7.4.3 Europe Contract Dose Manufacturing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Contract Dose Manufacturing Market Size (2019-2030)
8.2 China Contract Dose Manufacturing Market Size by Type
8.2.1 China Contract Dose Manufacturing Market Size by Type (2019-2024)
8.2.2 China Contract Dose Manufacturing Market Size by Type (2025-2030)
8.2.3 China Contract Dose Manufacturing Market Share by Type (2019-2030)
8.3 China Contract Dose Manufacturing Market Size by Application
8.3.1 China Contract Dose Manufacturing Market Size by Application (2019-2024)
8.3.2 China Contract Dose Manufacturing Market Size by Application (2025-2030)
8.3.3 China Contract Dose Manufacturing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Contract Dose Manufacturing Market Size (2019-2030)
9.2 Asia Contract Dose Manufacturing Market Size by Type
9.2.1 Asia Contract Dose Manufacturing Market Size by Type (2019-2024)
9.2.2 Asia Contract Dose Manufacturing Market Size by Type (2025-2030)
9.2.3 Asia Contract Dose Manufacturing Market Share by Type (2019-2030)
9.3 Asia Contract Dose Manufacturing Market Size by Application
9.3.1 Asia Contract Dose Manufacturing Market Size by Application (2019-2024)
9.3.2 Asia Contract Dose Manufacturing Market Size by Application (2025-2030)
9.3.3 Asia Contract Dose Manufacturing Market Share by Application (2019-2030)
9.4 Asia Contract Dose Manufacturing Market Size by Region
9.4.1 Asia Contract Dose Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Contract Dose Manufacturing Market Size by Region (2019-2024)
9.4.3 Asia Contract Dose Manufacturing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Contract Dose Manufacturing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Contract Dose Manufacturing Introduction
11.1.4 Lonza Revenue in Contract Dose Manufacturing Business (2019-2024)
11.1.5 Lonza Recent Developments
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Contract Dose Manufacturing Introduction
11.2.4 Catalent Revenue in Contract Dose Manufacturing Business (2019-2024)
11.2.5 Catalent Recent Developments
11.3 Aenova
11.3.1 Aenova Company Details
11.3.2 Aenova Business Overview
11.3.3 Aenova Contract Dose Manufacturing Introduction
11.3.4 Aenova Revenue in Contract Dose Manufacturing Business (2019-2024)
11.3.5 Aenova Recent Developments
11.4 Siegfried
11.4.1 Siegfried Company Details
11.4.2 Siegfried Business Overview
11.4.3 Siegfried Contract Dose Manufacturing Introduction
11.4.4 Siegfried Revenue in Contract Dose Manufacturing Business (2019-2024)
11.4.5 Siegfried Recent Developments
11.5 Recipharm
11.5.1 Recipharm Company Details
11.5.2 Recipharm Business Overview
11.5.3 Recipharm Contract Dose Manufacturing Introduction
11.5.4 Recipharm Revenue in Contract Dose Manufacturing Business (2019-2024)
11.5.5 Recipharm Recent Developments
11.6 Strides Shasun
11.6.1 Strides Shasun Company Details
11.6.2 Strides Shasun Business Overview
11.6.3 Strides Shasun Contract Dose Manufacturing Introduction
11.6.4 Strides Shasun Revenue in Contract Dose Manufacturing Business (2019-2024)
11.6.5 Strides Shasun Recent Developments
11.7 Piramal
11.7.1 Piramal Company Details
11.7.2 Piramal Business Overview
11.7.3 Piramal Contract Dose Manufacturing Introduction
11.7.4 Piramal Revenue in Contract Dose Manufacturing Business (2019-2024)
11.7.5 Piramal Recent Developments
11.8 Metrics Contract Services
11.8.1 Metrics Contract Services Company Details
11.8.2 Metrics Contract Services Business Overview
11.8.3 Metrics Contract Services Contract Dose Manufacturing Introduction
11.8.4 Metrics Contract Services Revenue in Contract Dose Manufacturing Business (2019-2024)
11.8.5 Metrics Contract Services Recent Developments
11.9 AMRI
11.9.1 AMRI Company Details
11.9.2 AMRI Business Overview
11.9.3 AMRI Contract Dose Manufacturing Introduction
11.9.4 AMRI Revenue in Contract Dose Manufacturing Business (2019-2024)
11.9.5 AMRI Recent Developments
11.10 Famar
11.10.1 Famar Company Details
11.10.2 Famar Business Overview
11.10.3 Famar Contract Dose Manufacturing Introduction
11.10.4 Famar Revenue in Contract Dose Manufacturing Business (2019-2024)
11.10.5 Famar Recent Developments
11.11 WuXi AppTech
11.11.1 WuXi AppTech Company Details
11.11.2 WuXi AppTech Business Overview
11.11.3 WuXi AppTech Contract Dose Manufacturing Introduction
11.11.4 WuXi AppTech Revenue in Contract Dose Manufacturing Business (2019-2024)
11.11.5 WuXi AppTech Recent Developments
11.12 Asymchem
11.12.1 Asymchem Company Details
11.12.2 Asymchem Business Overview
11.12.3 Asymchem Contract Dose Manufacturing Introduction
11.12.4 Asymchem Revenue in Contract Dose Manufacturing Business (2019-2024)
11.12.5 Asymchem Recent Developments
11.13 Porton
11.13.1 Porton Company Details
11.13.2 Porton Business Overview
11.13.3 Porton Contract Dose Manufacturing Introduction
11.13.4 Porton Revenue in Contract Dose Manufacturing Business (2019-2024)
11.13.5 Porton Recent Developments
11.14 Amatsigroup(Eurofins)
11.14.1 Amatsigroup(Eurofins) Company Details
11.14.2 Amatsigroup(Eurofins) Business Overview
11.14.3 Amatsigroup(Eurofins) Contract Dose Manufacturing Introduction
11.14.4 Amatsigroup(Eurofins) Revenue in Contract Dose Manufacturing Business (2019-2024)
11.14.5 Amatsigroup(Eurofins) Recent Developments
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Details
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Contract Dose Manufacturing Introduction
11.15.4 Thermo Fisher Scientific Revenue in Contract Dose Manufacturing Business (2019-2024)
11.15.5 Thermo Fisher Scientific Recent Developments
11.16 Piramal Pharma Solutions
11.16.1 Piramal Pharma Solutions Company Details
11.16.2 Piramal Pharma Solutions Business Overview
11.16.3 Piramal Pharma Solutions Contract Dose Manufacturing Introduction
11.16.4 Piramal Pharma Solutions Revenue in Contract Dose Manufacturing Business (2019-2024)
11.16.5 Piramal Pharma Solutions Recent Developments
11.17 AbbVie Contract Manufacturing
11.17.1 AbbVie Contract Manufacturing Company Details
11.17.2 AbbVie Contract Manufacturing Business Overview
11.17.3 AbbVie Contract Manufacturing Contract Dose Manufacturing Introduction
11.17.4 AbbVie Contract Manufacturing Revenue in Contract Dose Manufacturing Business (2019-2024)
11.17.5 AbbVie Contract Manufacturing Recent Developments
11.18 Baxter BioPharma Solutions
11.18.1 Baxter BioPharma Solutions Company Details
11.18.2 Baxter BioPharma Solutions Business Overview
11.18.3 Baxter BioPharma Solutions Contract Dose Manufacturing Introduction
11.18.4 Baxter BioPharma Solutions Revenue in Contract Dose Manufacturing Business (2019-2024)
11.18.5 Baxter BioPharma Solutions Recent Developments
11.19 Fareva
11.19.1 Fareva Company Details
11.19.2 Fareva Business Overview
11.19.3 Fareva Contract Dose Manufacturing Introduction
11.19.4 Fareva Revenue in Contract Dose Manufacturing Business (2019-2024)
11.19.5 Fareva Recent Developments
11.20 NextPharma
11.20.1 NextPharma Company Details
11.20.2 NextPharma Business Overview
11.20.3 NextPharma Contract Dose Manufacturing Introduction
11.20.4 NextPharma Revenue in Contract Dose Manufacturing Business (2019-2024)
11.20.5 NextPharma Recent Developments
11.21 Emergent BioSolution
11.21.1 Emergent BioSolution Company Details
11.21.2 Emergent BioSolution Business Overview
11.21.3 Emergent BioSolution Contract Dose Manufacturing Introduction
11.21.4 Emergent BioSolution Revenue in Contract Dose Manufacturing Business (2019-2024)
11.21.5 Emergent BioSolution Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Lonza
Catalent
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics Contract Services
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup(Eurofins)
Thermo Fisher Scientific
Piramal Pharma Solutions
AbbVie Contract Manufacturing
Baxter BioPharma Solutions
Fareva
NextPharma
Emergent BioSolution
听
听
*If Applicable.
